Key regions: France, Europe, United Kingdom, Brazil, India
The demand for Oncology Drugs in Egypt has been on a steady rise in recent years.
Customer preferences: The majority of the Egyptian population relies on public healthcare, which has limited resources for cancer treatment. This has created a gap in the market, which private healthcare providers have been filling. As a result, the demand for Oncology Drugs has increased, as they are the primary treatment for cancer.
Trends in the market: One of the key trends in the Oncology Drugs market in Egypt is the increasing prevalence of cancer. The country has a high incidence of cancer, with breast cancer being the most common type among women. This has led to an increase in the demand for Oncology Drugs, as they are the primary treatment for cancer.Another trend in the market is the increasing number of pharmaceutical companies entering the market. This has led to increased competition, which has resulted in lower prices for Oncology Drugs. This has made them more affordable for patients, which has further increased demand.
Local special circumstances: One of the key special circumstances in the Oncology Drugs market in Egypt is the limited resources available for cancer treatment in public healthcare. This has created a gap in the market, which private healthcare providers have been filling. As a result, the demand for Oncology Drugs has increased.Another special circumstance is the high incidence of cancer in the country. This has led to an increase in the demand for Oncology Drugs, as they are the primary treatment for cancer.
Underlying macroeconomic factors: One of the key macroeconomic factors driving the Oncology Drugs market in Egypt is the increasing population. With a growing population, the number of cancer cases is also increasing, which has led to an increase in the demand for Oncology Drugs.Another macroeconomic factor is the increasing income levels in the country. As income levels rise, more people are able to afford private healthcare, which has further increased demand for Oncology Drugs.In conclusion, the Oncology Drugs market in Egypt is on a steady rise, driven by the increasing prevalence of cancer, the limited resources available for cancer treatment in public healthcare, the increasing number of pharmaceutical companies entering the market, and the increasing population and income levels in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
